Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma (GB:TCF)
:TCF
TCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.48p - 1.39p
Previous CloseN/A
Volume87.69K
Average Volume (3M)1.11M
Market Cap
£4.30M
Enterprise Value1.98M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Jun 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding429,622,440
10 Day Avg. Volume353,121
30 Day Avg. Volume1,113,879
Standard Deviation0.29
R-Squared0.07
Alpha-0.00091
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.85
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Evgen Pharma News
PremiumCompany Announcements
TheraCryf Raises £4.25 Million to Advance Drug Development
PremiumCompany Announcements
TheraCryf Appoints Dr. Alastair Smith as Non-executive Chair
PremiumCompany Announcements
TheraCryf Expands Pipeline with Chronos Acquisition
PremiumCompany Announcements
TheraCryf Secures European Patent for Ox-1 Antagonist
PremiumCompany Announcements
TheraCryf Expands Equity with New Share Issue
PremiumCompany Announcements
TheraCryf plc to Announce Interim Results in NovemberPremiumCompany Announcements
TheraCryf Reports Positive SFX-01 Study Results
PremiumCompany Announcements
TheraCryf Mourns Loss of Chair Dr. Sue Foden---
Options Prices
Currently, No data available
---
Ownership Overview
TCF FAQ
What was Evgen Pharma’s price range in the past 12 months?
Evgen Pharma lowest share price was 0.48p and its highest was 1.39p in the past 12 months.
What is Evgen Pharma’s market cap?
Evgen Pharma’s market cap is £4.30M.
When is Evgen Pharma’s upcoming earnings report date?
Evgen Pharma’s upcoming earnings report date is Jun 11, 2025 which is in 112 days.
How were Evgen Pharma’s earnings last quarter?
Evgen Pharma released its earnings results on Nov 28, 2024. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
Is Evgen Pharma overvalued?
According to Wall Street analysts Evgen Pharma’s price is currently Overvalued.
Does Evgen Pharma pay dividends?
Evgen Pharma does not currently pay dividends.
What is Evgen Pharma’s EPS estimate?
Evgen Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evgen Pharma have?
Evgen Pharma has 429,622,440 shares outstanding.
What happened to Evgen Pharma’s price movement after its last earnings report?
Evgen Pharma reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.818%.
Which hedge fund is a major shareholder of Evgen Pharma?
Currently, no hedge funds are holding shares in GB:TCF
---
Company Description
Evgen Pharma
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, it operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.
---
Technical Analysis
HUTCHMED (China) Limited
―
ImmuPharma
―
Sareum Holdings
―
Scancell Holdings
―
Oxford BioMedica
―
---